Pharmarise Holdings Corporation

TSE:2796.T

616 (JPY) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

20232022202120202019201820172016201520142013201220112010200920082007
Operating Activities:
Net Income -3511,0491,3221,20281940041411,024.793943.4541,156.0891,631.1471,435.5241,172.143580.645442.373262.446
Depreciation & Amortization 1,1701,2241,3081,3441,2281,2231,3261,2931,199.0911,158.0831,081.682835.839672.1603.035448.888395.26352.955
Deferred Income Tax 0000-270-562182-215-412.608-930.842-627.883000000
Stock Based Compensation 00003740282930.10836.12834.416000000
Change In Working Capital 1,785513-1,465-139-612-258-805754-1,621.1962,050.138-724.536330.775759.217-405.611-99.574577.814156.005
Accounts Receivables 1,481482-1,319365373228-1,0611,634-117.706895-23247700000
Inventory -266828656-34212148-23270.163-75.75980.41327.65550.193-34.495113.07201.803757.868
Accounts Payables 13713-500-582-258-50646-648-1,573.65300000000
Other Working Capital 193-506822-3858-953986-1,691.3592,125.897-804.949303.12709.024-371.116-212.644376.011-601.863
Other Non Cash Items 858-266-452-46237052185241-492.946148.132386.352-1,179.522-583.007-427.15-122.593-142.931709.003
Operating Cash Flow 2,7142,5207131,9451,5728951,3302,103-272.7583,405.0931,306.121,618.2392,283.834942.417807.3661,272.5161,480.409
Investing Activities:
Investments In Property Plant And Equipment -619-542-466-552-457-458-405-576-564.004-633.122-885.101-1,135.452-564.078-366.055-170.044-759.043-977.023
Acquisitions Net -2,370-1802-116-468-197-131-111-28.307-17.183-120.701-475.0640045.947-86.837-183.871
Purchases Of Investments 00-2-226-10-5-336-349.956-344.288-914.669-3,324.516-1,100.299-386.19-1,526.983-120.5-253.29
Sales Maturities Of Investments 4303831210163651277.4155.17265.876173.1910089.307-15.62-368.896
Other Investing Activites -17519-209-41815518101-108.902-74.767146.248166.159244.482-21.006-50.59792.89211.668
Investing Cash Flow -3,120-703-292-1,076-734-501-527-871-773.754-1,064.188-1,708.347-4,595.682-1,419.895-773.251-1,612.37-889.11-1,571.412
Financing Activities:
Debt Repayment -3,314-2,419-2,636-2,857-2,829-3,114-3,153-3,922-3,291.615-3,529.616-3,601.527-3,840.562-2,871.856-2,272.15-1,819.56-1,743.236-2,165.137
Common Stock Issued 001,7372,1992,367103000.0010.004900.545010.5461.1253,424.1591,883.3550
Common Stock Repurchased -3400-2-36-1733,492004,155.5181,554.8213,296.03403,179.8032,379.435-85.878-2.430
Dividends Paid -127-131-131-129-129-125-126-125-143.367-125.993-105.004-75.003-65.002-40.602-42.804-42.93-42.93
Other Financing Activities -731,478-295-2-22,3853,231-228.0750.001-0.0026,031.993-0.002-0.001-0.001-0.0022,046.995
Financing Cash Flow 2,771-1,072-1,034-728-766354-894-816492.462-2,100.783490.0462,116.428253.443527.8071,475.91694.757-161.072
Other Information:
Effect Of Forex Changes On Cash 0-20-1-120-1000.0010.0010.001-0.00100.002-0.001
Net Change In Cash 2,358743-61314071750-91415-554.05240.12287.82-861.0141,117.383696.972670.912478.165-252.076
Cash At End Of Period 7,1004,7343,9914,6044,4644,3933,6433,7343,319.3723,873.4223,633.33,545.484,406.4943,289.1112,592.1391,921.2271,443.062